---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-157444"
form_type: "8-K"
ticker: "MNKD"
cik: "0000899460"
company_name: "MANNKIND CORP"
filed_at: "2022-05-23T23:59:59+00:00"
generated_at: "2026-06-25T08:28:53.255394+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# MannKind to acquire V-Go device from Zealand Pharma for $10M plus up to $17M in inventory and milestones

## Summary
- Purchase price: $10.0M plus book value of finished goods inventory (not to exceed $7.0M) and up to $10.0M in sales-based milestone payments.
- Milestone payments triggered when annual V-Go revenue reaches thresholds between $40M and $100M.
- Company will assume a facility lease in Marlborough, MA with monthly payments of $28,895, expiring Feb 2026.
- Up to 40 current and former Zealand employees to be offered positions, including field sales and supply chain roles.
- Closing expected in May 2022 subject to satisfaction of customary conditions.

## SEC filing metadata
- accession: 0001193125-22-157444
- form_type: 8-K
- ticker: MNKD
- cik: 0000899460
- company_name: MANNKIND CORP
- filed_at: 2022-05-23T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.03, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/899460/000119312522157444/0001193125-22-157444-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/899460/000119312522157444/d283470d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-157444
- JSON: https://secwatch.observer/filing/0001193125-22-157444.json
- Plain text: https://secwatch.observer/filing/0001193125-22-157444.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.